Trial NCT01203618

View at ClinicalTrials.gov 
Org. Study IDs: MORAb-003-007

Last trial update was posted on 2013-11-03

MeSH Interventions

Farletuzumab

MeSH Conditions

Adenoma Pituitary Diseases Pituitary Neoplasms

Other Conditions

Resectable, Non-functioning Pituitary Adenoma

Stopping Reasons

Trial terminated due to focus of primary therapeutic areas.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID